About IPCD: Connecting BITS Pilani to the World

BITS Pilani came into existence as a Deemed-to-be University under Section 3 of the UGC Act in the year 1964. In its formative years, the Institute partnered with the Massachusetts Institute of Technology (MIT) in Boston, USA. It adopted a semester system, a modular structure of courses, continuous and internal evaluation, letter grading, and the like. It also created linkages with the industries, which yielded structured “Practice Schools” as an integral component of education. To further expand collaborative participation in research and teaching, Memoranda of Understanding (MOUs) have been signed with various universities and industries both domestically and internationally. This would strengthen educational and research linkages, as well as the exchange of faculty and students, to achieve state-of-the-art infrastructure facilities in various fields of Engineering and Science.

The Role and Scope of the Technology Transfer Office at BITS Pilani

  • Identify potential Technology Transfer Activities and Intellectual Property issues relating to innovations, scientific discoveries and inventions.
  • Capitalise on the Innovations made, having potential for a commercial ventures.
  • Advise and facilitate the Faculty in understanding relevant intellectual property and technology transfer issues, including developing and interpreting policy.
  • Represent the Institute's interest in intellectual property and technology transfer to external organisations.

Technologies Ready for Transfer

Description:

The invention relates to the development of a polymeric micellar system for glutathione-mediated intracellular delivery of the photosensitizer chlorin e6 (Ce6) by synthesising an amphiphilic polymer, methoxy-poly(ethylene glycol)-poly(D, L-lactide) disulfide-Ce6 (mPEG-PLA-S-S-Ce6), which self-assembles in aqueous media to form micelles. The nanocarrier system for faster drug release and enhanced therapeutic effect. The GSH-mediated intracellular drug delivery was studied in mouse mammary carcinoma cells (4T1) and human alveolar adenocarcinoma cells (A549) by pretreating the cells with either buthionine sulfoximine (BSO) or glutathione monoester (GSH-OEt), thereby increasing or decreasing cytoplasmic GSH levels.


Key Features & Benefits:

  • The micellar form of Ce6 improves solubility, stability, and cellular uptake, as well as passive tumour-targeted delivery, thereby reducing non-specific side effects.
  • mPEG-PLA-S-S-Ce6 polymeric micelles are a surprisingly effective redox-responsive system for Ce6-mediated photodynamic therapy.

Innovator(s):

Swati Biswas, Balaram Ghosh, Preeti Kumari, Department of Pharmacy, Birla Institute of Technology and Science - Pilani, Hyderabad Campus


Potential Application& Industries:

We would promote the application of this drug delivery system to pharmaceutical companies developing nanoformulations for cancer therapy. However, given the pharmaceutical industry/customer interest in certain cancers and chemotherapeutic agents, our drug delivery system will be validated in additional animal models or advanced to the next stage.


Patent Status: Granted


Is proof-of-concept (PoC) available? : Yes


Current TRL Level:3


Click Here for a Snapshot

Technology Description:

  • This invention is an amalgam of hardware and software systems. The developed hardware will be used to acquire quality images, whereas the developed software will process the captured images to get the desired output.
  • The hardware features two 4MP industrial cameras, mounted on an opal-frosted white acrylic sheet supported by backlit LEDs with adjustable light intensity, with silver foil on the enclosed side.
  • From a software perspective, the overall processing is divided into two broad categories based on the techniques used. One category is based on image processing, and the other is based on the application of a deep learning algorithm.

Key Features & Benefits:

  • It will help identify assembly fastening elements with greater accuracy and in less time.
  • It will also be useful for determining the dimensions (length, width/diameter, and pitch) of fastening components.
  • It will also be useful for approving and maintaining a record of all fastening elements entering different levels of assembly integration.

Innovators: Faisal Mushtaq, Kaki Ramesh, Sandip Shridharrao Deshmukh, Chandu Parimi, Tathagata Ray, Praveen Tandon, Pramod Jha (Jointly filed by DRDO and Mechanical Engineering, BITS Pilani, Hyderabad Campus)


Potential Application & Industries: Mechanical and Manufacturing industries


Patent Status: Filed in India


Patent #: 202111054493


Is proof-of-concept (PoC) available? Yes


Current TRL Level: TRL-

Description:

The present invention relates to a biodegradable ocular patch for treating eye infections and a method of preparing the same.


Key Features & Benefits:

  • The product of the present invention overcomes the stability issues of amphotericin
  • It enables sustained drug release to reduce the frequency of administration
  • Increase patient compliance

Innovator(s):

Nirmal Jayabalan, Velmurugan Kailasam, Prashant Garg, Department of Pharmacy, Birla Institute of Technology and Science - Pilani, Hyderabad Campus


Potential Application& Industries:

  • The formulation can be used for ocular diseases
  • Scalable for industries

Patent Status: Filed


Is proof-of-concept (PoC) available? : Yes


Current TRL Level:3


Click Here for a Snapshot

Description:

A nanomicellar formulation loaded with natamycin to treat ocular fungal infection. Nanomicelles enhance the solubility and permeation of natamycin across the cornea.


Key Features & Benefits:

  • Improving the corneal permeation and solubility of natamycin.
  • Reducing dose and dosing frequency.
  • Hence, improving patient compliance.

Innovator(s):

Nirmal, Jayabalan, Priyadarshini Sathe, Velmurugan Kailasam, Prashant Garg


Department & Campus:

Pharmacy, Hyderabad


Potential Application& Industries:

  • The method of preparation has potential for large-scale production.
  • The formulation can be used to treat ocular fungal infections.

Patent Status: Provisional patent filed


Patent #:IN202111058586


Is proof-of-concept (PoC) available? : Yes


Current TRL Level:3

Description:

The present invention relates to a system and method for determining the viscosity of a fluid and, more particularly, to a microfluidic-based system and method for determining the viscosity of a fluid.


Key Features & Benefits:

Analytical tools for the biological and chemical sciences


Innovator(s):

Sanket Goel and Puneeth S B, Department & Campus: EEE, Hyderabad Campus


Potential Application:

  • Handheld and portable with miniaturised electronics
  • For monitoring the adulteration of various fluids

Potential Industries:

  • Automobiles industry
  • Healthcare sector
  • Food / Milk industry

Validation & Trials Conducted: Trials conducted on milk and automobile fuel Samples


Patent Status: Filed (India)


Patent #:201711031122


Is proof-of-concept (PoC) available? : Yes


Current TRL Level:4

Description:

Microfluidic electro-viscometer to determine the relative viscosity of a fluid. The invention also relates to a process for preparing the microfluidic electro-viscometer to determine the relative viscosity of a fluid, as well as a method of determining the relative viscosity of a sample fluid.


Key Features & Benefits:

Analytical tools for the biological and chemical sciences


Innovator(s):

Sanket Goel and Puneeth S B, Department & Campus: EEE, Hyderabad Campus


Potential Application:

  • Handheld and portable with miniaturised electronics
  • For monitoring the adulteration of various fluids

Potential Industries:

  • Automobiles industry
  • Healthcare sector
  • Food / Milk industry

Validation & Trials Conducted: Trials conducted on milk and automobile fuel Samples


Patent Status: Filed (India)


Patent #:201711031122


Is proof-of-concept (PoC) available? : Yes


Current TRL Level:5

Description:

To develop an IoT-driven portable microthermofluidic system for synthesising MnO2 nanoparticles with a microfluidic platform. This thermal management system can be used as a universal device for biochemical and biomedical POCT applications.


Key Features & Benefits:

  • Temperature sensitivity of ±0.2°C
  • Low Power ~12V
  • Smartphone-enabled IoT system
  • POCT device

Innovator(s):

Sanket Goel, Madhusudan B Kulkarni and Yashas, Department & Campus: EE, BITS Pilani, Hyderabad campus


Potential Application:

  • Nanomaterial Synthesis
  • DNA Amplification – PCR, LAMP RPA
  • Protein Denaturation
  • Biochemical Process

Potential Industries:

  • Pharmaceutical
  • Healthcare
  • Agriculture and Food
  • Chemical\Clinical laboratories
  • Diagnostic laboratories

Any relevant data for marketing: Fully integrated, automated, and miniaturised microthermofluidic system validated and compared to a benchtop instrument


Patent Status: Filed in India


Patent #:202011017181


Is proof-of-concept (PoC) available? : Yes


Current TRL Level:5

Description:

The present invention relates to a device for making designs on a substrate.


Key Features & Benefits:

Reduction in errors caused by manual pencil graphite deposition and improvement in the repeatability of fabricated paper-based devices


Innovator(s):

Lanka Tata Rao, Arshad Javed, Satish Kumar Dubey and Sanket Goel, Department of Mechanical Engineering & Department of Electronics & Electrical Engineering, Birla Institute of Technology & Science - Pilani, Hyderabad Campus


Potential Application:

  • Medical Diagnostics
  • Miniaturised fuel cell
  • LIF sensors

Potential Industries:


Point-of-care systems industry


Patent Status: Filed (India)


Is proof-of-concept (PoC) available? : Yes


Current TRL Level:5


Any other relevant information :


Fully developed and trials conducted.


Click Here for a Snapshot

Description:

A wearable Electronic Nasal Air Filter for daily protection from air pollution and pollutants


Key Features & Benefits:

  • An inexpensive process for monitoring and detecting pollutants
  • A wearable Electronic Nasal Air Filter for daily protection from air pollution and pollutants
  • Easy to plug and handle for the quantification

Innovator(s):

Avinash Kothuru and Sanket Goel, Department of Electronics & Electrical Engineering, Birla Institute of Technology and Science - Pilani, Hyderabad Campus


Potential Application & Industries:

  • Economical and scalable fabrication of wearable fuel cells and sensors
  • Capable of use for wearable sensing applications, along with fuel cell applications

Patent Status: Pending/India


Is proof-of-concept (PoC) available? : Yes


Current TRL Level:4


Any other relevant information :

  • Fully integrated and miniaturised device,
  • Lab validated

Click Here for a Snapshot

Description:

Low-cost, ultraportable, microfluidic colourimetric device for point-of-care applications to quantify and monitor environmental and biological analytes.


Key Features & Benefits:

  • Plug and Play for Multiplexed Detection
  • Integrated microfluidic chip for enhanced and highly repeatable colourimetric detection
  • Portable Colourimetric Sensor

Innovator(s):

Abhishesh Pal, Madhudusan B. Kulkarni, Ponnalagu R. N., Satish K Dubey & Sanket Goel, Department of Mechanical Engineering, Birla Institute of Technology & Science - Pilani, Hyderabad Campus


Potential Application:

  • Soil and Water Parameter Quantification
  • Biological Chromophores

Potential Industries:

  • Soil Testing and Analysis
  • Point of Care Bioanalysis Testing Kits

Patent Status: Filled in India


Is proof-of-concept (PoC) available? : Yes


Current TRL Level:5


Any other relevant information :

  • The device was tested to quantify Phosphate and Nitrite using colourimetric detection
  • Validation was carried out using a standard spectrophotometer at the peak absorption wavelength

Click Here for a Snapshot

Description:

Enzymatic biofuel cells have attracted significant interest due to their simplicity and the recent key advances in point-of-sale (POS) and point-of-care (POC) device development. This invention involves the fabrication of accurate electrodes on paper for sensing, energy harvesting, and flexible electronics applications.


Key Features & Benefits:

  • Creating automated pencil strokes for bioelectrodes, which can be used for instant energy harvesting from biofuels.
  • Economic and disposable paper-based electrodes
  • Developed bioelectrodes can be used as both a sensing and a powering source.

Innovator(s):

Jayapiriya U S and Sanket Goel, Department & Campus: EEE & BITS Pilani, Hyderabad campus


Department & Campus:

Pharmacy, Hyderabad


Potential Application & Industries:

  • Economical and scalable fabrication of wearable fuel cells and sensors.
  • Capable of use for wearable sensing applications, along with fuel cell applications.

Any other relevant information/data: Fully integrated, automated, and miniaturised device lab validated.


Patent Status: Filed in India


Patent #:202111017427


Is proof-of-concept (PoC) available? : Yes


Current TRL Level:4

Description:

Useful for the treatment of Parkinson's disease and other disorders for which dopamine monitoring is therapeutically useful. A reusable, 3D-printed, leak-proof sample chamber with a slot for inserting a disposable mini cartridge, manufactured using an easy, quick technique, has been developed. It shows a low detection limit, good reproducibility, and fast response.


Key Features & Benefits:

  • Point of care (POC)
  • Rapidity, simplicity
  • Performing diagnostics near the healthcare facility

Innovator(s):

Sanket Goel, S K Sahoo, and Mrunali Wagh, Department & Campus: EEE, Hyderabad Campus


Department & Campus:

Pharmacy, Hyderabad


Potential Application:

  • Sensing of multiple analytes in biological fluids
  • Simultaneously, biological Sample Analysis

Potential Industries:

Medical Diagnostics


Validation & Trials Conducted:

  • Trials conducted on biological Samples
  • LoD —> 0.47 µM

Patent Status: Filed (India)


Patent #:202111059663


Is proof-of-concept (PoC) available? : Yes


Current TRL Level:4

Description:

A novel liposomal formulation of the Bruton’s Tyrosine Kinase (BTK) inhibitor ibrutinib has been developed, with the potential to enhance its effectiveness for the intended clinical application. The developed surface-modified liposomal formulation is based on the encapsulation of the drug (Ibrutinib) within lipid vesicles. Moreover, the stability of this formulation would be further improved by developing a suitable, robust lyophilisation recipe.


Key Features & Benefits:

Development of a stable liposomal formulation of Ibrutinib for increased bioavailability and reduced off-target toxicity. Additionally, modifying the liposome surface with a polymer would further enhance the drug's activity and longevity.


Innovator(s):

Dr. Akash Chaurasiya, Ms. Kanan Panchal, Department of Pharmacy, Birla Institute of Technology & Science - Pilani, Hyderabad Campus


Potential Application & Industries:

Development of an effective, robust and stable formulation with high reproducibility.


Patent Status: Filled in India


Is proof-of-concept (PoC) available? : Yes


Current TRL Level:


Any other relevant information :


Approvals/Compliances met / Validation/trials conducted.


Click Here for a Snapshot

Description:

The proposed novel formulation consists of a mixture of oil(s) (e.g., Clove oil, Cinnamon oil), surfactant(s), and co-surfactant(s), which facilitate the solubilization/dissolution and absorption of posaconazole in the gastrointestinal tract upon oral administration. This isotropic mixture of oil, surfactant, and co-surfactant enhances the bioavailability of the loaded drug in several ways, including stimulating lymphatic transport, prolonging its GI residence time, increasing intestinal wall permeability, reducing its efflux in the GIT, stimulating body secretion, etc.


Key Features & Benefits:

Application of a suitable combination of surfactant and co-surfactant in optimised amounts stabilises the formulation, facilitates drug solubilisation, thereby enhancing bioavailability, and possesses suitable therapeutic applications in fungal infections. The manufacturing technique is simple, easy to scale up, and cost-effective.


Innovator(s):

Dr. Akash Chaurasiya, Mr. Sumeet Katke, Ms.Kanan Panchal, Department of Pharmacy, Birla Institute of Technology & Science - Pilani, Hyderabad Campus


Patent Status: Filled in India


Is proof-of-concept (PoC) available? : Yes


Current TRL Level:


Click Here for a Snapshot

Description:

The present invention relates to a device with double-sided herringbone structures for enrichment of CAR-T cells using a continuous-flow microfluidic device.


Key Features & Benefits:

The final design provides a microfluidic device comprising

  • 2 pairs of hexagonal channels connected via 1 inlet and 2 outlets
  • The herring-bone structure is being utilised to optimise cell capture and retention within the individual channels.

Benefits include:

  • They require fewer reagents and samples as inputs, reducing significant costs in device maintenance and operations.
  • They are easily portable and can be used in the field.
  • Easier to handle.
  • They are made of a polymer, so they function as a throughput device and can be reused multiple times.
  • Being smaller, they require less storage space.
  • User-friendly.
  • Being small in size and made of relatively inexpensive materials, these devices have a low production cost.

Innovator(s):

Jegatha Nambi Krishnan, Prasanna Gururaj Joshi, Arya Agarwal, Rai Divakar, Hegde Ritvik, Singh Sarthak, Department of Chemical Engineering, Birla Institute of Technology and Science - Pilani, K K Birla Goa Campus


Potential Application & Industries:

The primary application of the invention will be ‘Monitoring the CAR-T cells in a Clinical Setting’. This is a necessary function to ensure the viability of the cells before transfusing them into the patient’s body for treatment


Patent Status: Filled in India


Patent#: 202111058598


Is proof-of-concept (PoC) available? : Yes


Current TRL Level:3


Any other relevant information :


The profiles for pressure, velocity, and the particle trajectory within blood for the device have been obtained using COMSOL Multiphysics.


Click Here for a Snapshot

Description:

A treatment process for cellulose-based geotextile process


Key Features & Benefits:

  • Over existing technology solutions
  • A process for treating a cellulose-based geotextile fibre comprising the steps of:
  • Preparing an aqueous alkaline solution;
  • Reacting coal combustion byproduct with the solution of
  • to obtain a polymerised blend, and apply the blend obtained in
  • to the geotextile fibre.

Innovator(s):

Anasua GuhaRay, Arkamitra Kar and Shashank Gupta, Department of Civil Engineering, Birla Institute of Technology & Science - Pilani, Hyderabad Campus


Potential Application & Industries:

Improvement in the durability of natural geotextiles for the sustainable construction of reinforced foundation beds, slope stability, etc.


Patent Status: Filled in India


Is proof-of-concept (PoC) available? : Yes


Current TRL Level:8


Any other relevant information :


Successful trials conducted at the laboratory level


Click Here for a Snapshot

Description:

A novel material which can be used as an alternative to existing biomaterials in the field of orthopaedic and dental implants, and the manufacturing method for the same.


Key Features & Benefits:

Among existing implant biomaterials, our novel material possesses properties closer to those of natural bone, in addition to being biocompatible and bioactive. Young's modulus of natural bone is 10.4 GPa (standard deviation: 3.5), whereas it is 7GPa (standard deviation: 0.5) for our biomimetic composite. Hydroxyapatite (HA), as one of the constituents of the material, renders the material bioactive, while all other constituents are biocompatible.


Innovator(s):

Kulkarni Dhananjay Madhukar, Iniyan Thiruselvam N, Mali Kiran Dinkar, Savio DSA Lourenco, Department of Mechanical Engineering, Birla Institute of Technology and Science - Pilani, K K Birla Goa Campus


Potential Application & Industries:

Dental & Orthopaedic implants


Patent Status: Pending


Is proof-of-concept (PoC) available? : Yes


Current TRL Level:4


Any other relevant information :


Preliminary material testing is over.


Click Here for a Snapshot

Description:

A low-cost synthetic media combination for higher biomass growth in microalgae culture, coupled with higher net lipid productivity; the high cost of microalgae-based biodiesel has constrained economic competitiveness and significantly restricted industrialisation. To commercialise a process for producing valuable products from microalgae, it is important to enhance microalgae growth rates and reduce cultivation costs.


Key Features & Benefits:

  • Low-cost nutrient medium
  • Increasing the lipid content
  • Reducing the cost of biodiesel production

Innovator(s):

Sama Sanghamitra, Sandip Shridharrao Deshmukh, Kumar Pranav Narayan, Department of Mechanical Engineering, Birla Institute of Technology and Science - Pilani, Hyderabad Campus


Potential Application & Industries:

  • A low-cost synthetic media combination for higher biomass growth of microalgae culture coupled with higher net lipid productivity.
  • Low-cost Biodiesel production
  • Commercialising the microalgae biomass production and biodiesel production.

Patent Status: Filed


Is proof-of-concept (PoC) available? : Yes


Current TRL Level:4


Any other relevant information :


Preliminary material testing is over.


Click Here for a Snapshot

Description:

iSTAR® is an anaerobic reactor technology developed for efficient biomethanation of organic waste.


Key Features & Benefits:

STAR® has the following unique features of single-stage anaerobic digestion:

  • Maintains homogeneous substrate concentration in the reactor
  • Maintains uniform temperature throughout the reactor
  • Continuously monitors critical parameters of the reactor
  • Reduces the overall energy consumption of the system

Innovator(s):

Sankar Ganesh Palani, Department of Biological Sciences, Birla Institute of Technology and Science - Pilani, Hyderabad Campus


Potential Application & Industries:

  • Treatment of organic (solid and liquid) wastes
  • Bioreactor fabricating and waste & wastewater treatment industries

Patent Status: Filed in India


Is proof-of-concept (PoC) available? : Yes


Current TRL Level:7


Any other relevant information/data (non-proprietary) for marketing:

  • Ready to launch at industry scale
  • Ideal for urban & rural local bodies, restaurants, institutions and gated communities
  • Subsidy on capital cost from the Ministry of New and Renewable Energy, Government of India

Click Here for a Snapshot

Description:

An antenna for ultrawideband (2 GHz-20 GHz), useful for both low- and high-power applications. The antenna has high gain (20 dB) and a compact structure.


Key Features & Benefits:

Over existing technology solutions:

  • Highly compact antenna
  • Lightweight structure
  • Ultra-wideband frequency

Innovator(s):

Ashish Chittora, Swati Varun Yadav, Department of Electronics & Electrical Engineering, Birla Institute of Technology & Science - Pilani, K K Birla Goa Campus


Potential Application & Industries:

  • Ground penetrating radar
  • Microwave imaging
  • UWB systems

Patent Status: Filed in India


Is proof-of-concept (PoC) available? : Yes


Current TRL Level:3


Any other relevant information/data (non-proprietary) for marketing:


Prototype developed, experimentally validated in the lab.


Click Here for a Snapshot

Description:

This invention relates to a chemotherapeutic composition for treating malignant tumours comprising suberoylanilide hydroxamic acid (SAHA) entrapped in a polymeric micelle comprising multiple copolymers of polyethene glycol (PEG) and polylactide-co-glycolic acid (PLGA). The invention also relates to a method of preparing the said composition.


Key Features & Benefits:

  • A chemotherapeutic composition for treating malignant tumours comprising suberoylanilide hydroxamic acid (SAHA) entrapped at the hydrophobic core of a polymeric micelle, encapsulation efficiency being between 70-100%, the micelle being 50 to 250 nm in size and comprising multiple copolymers of polyethene glycol (PEG) and polylactide-co-glycolic acid (PLGA), the copolymers clustering together at their hydrophobic PLGA ends to form polymeric micelles, each copolymer comprising one amine-terminated PEG molecule coupled to one acid-terminated PLGA molecule, resulting in an amphiphilic copolymer PEG-PLGA.
  • Polymeric micelles improved aqueous solubility and enhanced anti-tumour activity and cytotoxicity in vitro and in vivo when compared to the free form of SAHA.

Innovator(s):

Swati Biswas, Balaram Ghosh, Vishnu Kiran Rompicharla, Department of Pharmacy, Birla Institute of Technology & Science - Pilani, Hyderabad Campus.


Potential Application & Industries:

We would promote the application of this drug delivery system to pharmaceutical companies developing nanoformulations for cancer therapy.


Patent Status: Published


Patent #: (Application no 201711028012)


Is proof-of-concept (PoC) available? : Yes


Current TRL Level:4


Click Here for a Snapshot

Start Your Journey

Explore important dates, eligibility criteria, and
application details for BITSAT.